These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3902143)

  • 1. Antiviral therapy in hepatitis B infection.
    Thomas HC; Scully LJ
    Br Med Bull; 1985 Oct; 41(4):374-80. PubMed ID: 3902143
    [No Abstract]   [Full Text] [Related]  

  • 2. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.
    Schalm SW; Heytink RA; van Buuren HR; de Man RA
    Lancet; 1985 Aug; 2(8451):358-60. PubMed ID: 2862516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment of chronic type B hepatitis.
    Hoofnagle JH
    Ann Intern Med; 1987 Sep; 107(3):414-5. PubMed ID: 2441635
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon in chronic hepatitis B.
    Gregory PB
    Gastroenterology; 1986 Jan; 90(1):237-40. PubMed ID: 3940248
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B virus infection.
    Lee WM
    N Engl J Med; 1997 Dec; 337(24):1733-45. PubMed ID: 9392700
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and treatment of virus hepatitis B.
    Sherlock S
    Indian J Gastroenterol; 1984 Jan; 3(1):29-31. PubMed ID: 6241924
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B virus infection.
    Dienstag JL
    N Engl J Med; 2008 Oct; 359(14):1486-500. PubMed ID: 18832247
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G; Meyer zum Büschenfelde KH
    Immunobiology; 1986 Sep; 172(3-5):255-61. PubMed ID: 3643162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Laboratory diagnosis of hepatitis B].
    Forns X; Sánchez-Tapias JM
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():7-14. PubMed ID: 11279897
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
    Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
    J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynamics of hepatitis B virus infection.
    Ribeiro RM; Lo A; Perelson AS
    Microbes Infect; 2002 Jul; 4(8):829-35. PubMed ID: 12270730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B: weighing the costs of treatment.
    Angus PW
    J Gastroenterol Hepatol; 2002 Jul; 17(7):737-8. PubMed ID: 12121501
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot study of BW A515U (6-deoxyacyclovir) in chronic hepatitis B virus infection.
    Weller IV; Tedder RS; Karayiannis P; Thomas HC; Fiddian AP
    J Hepatol; 1986; 3 Suppl 2():S119-22. PubMed ID: 3598153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines.
    Idilman R
    Turk J Gastroenterol; 2017 Nov; 28(6):518-521. PubMed ID: 29082891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating the maze of hepatitis B treatments.
    Lok AS
    Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.